SCHEMBL5137747

SCHEMBL5137747

ON=C1CC2(CCN(Cc3ccccc3)CC2)c2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 14/20 0.52
CYP3A4 P08684 3/20 0.52
TP53 P04637 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2D6 P10635 2/20 0.52
TSHR P16473 2/20 0.52
CYP2C19 P33261 2/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP2C9 P11712 1/20 0.52
DRD2 P14416 3/20 0.50
HTR2A P28223 3/20 0.50
HTR2C P28335 3/20 0.50
HTR2B P41595 3/20 0.50
NFKB1 P19838 1/20 0.50
MAPK1 P28482 1/20 0.50
MTOR P42345 1/20 0.50
MEN1 O00255 1/20 0.49
BLM P54132 1/20 0.49
PMP22 Q01453 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5137746 1.00 SIGMAR1 (0.52) SIGMAR1CYP3A4TP53CYP1A2CYP2D6
SCHEMBL1713596 0.80 SIGMAR1 (0.59) SIGMAR1CYP3A4TP53CYP1A2CYP2D6
SCHEMBL2101748 0.77 MEN1 (0.48) SIGMAR1CYP2C19ALDH1A1HTR2AHTR2C
SCHEMBL13001590 0.77 MEN1 (0.48) SIGMAR1CYP2C19ALDH1A1HTR2AHTR2C
SCHEMBL11546653 0.77 HPGD (0.41) CYP1A2CYP2C19ALDH1A1MAPK1MEN1
SCHEMBL11546655 0.77 HPGD (0.41) CYP1A2CYP2C19ALDH1A1MAPK1MEN1
SCHEMBL20225530 0.76 SIGMAR1 (0.54) SIGMAR1CYP3A4TP53CYP1A2CYP2D6
SCHEMBL20549006 0.76 SIGMAR1 (0.54) SIGMAR1CYP3A4TP53CYP1A2CYP2D6
SCHEMBL12017851 0.76 SIGMAR1 (0.68) SIGMAR1CYP3A4DRD2HTR2AOPRL1
SCHEMBL12019172 0.76 SIGMAR1 (0.68) SIGMAR1CYP3A4DRD2HTR2AOPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110023315-B Novel compound or pharmacologically acceptable salt thereof 国立研究开发法人理化学研究所 2021-11-12 CN disclosed
EP-1987034-A1 SPIRO CONDENSED PIPERIDNES AS MODULATORS OF MUSCARINIC RECEPTORS Vertex Pharmceuticals Incorporated (US) 2008-11-05 EP disclosed
WO-2007100670-A1 SPIRO CONDENSED PIPERIDNES AS MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-09-07 WO disclosed